NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- Red Light Therapy May Actually Be the Fountain of Youth on February 24, 2019 at 5:41 am
But the science behind red light therapy is incredibly promising. "Realistically, you can expect RLT to improve your skin’s tone and texture," Dr. Klein says. "We know that it soothes inflammation, im... […]
- Compression Therapy Market 2015-2025 : Key Players Are SIGVARIS, BSN Medical GmbH on February 23, 2019 at 9:03 am
Compression Therapy is a process of applying external pressure to ... increases the drainage of nocious substances, reduces pain and inflammation. A common myth prevailing among people is that compres... […]
- Marker of inflammation associated with depression in patients with lung cancer on February 23, 2019 at 6:13 am
and lung cancer may provide a unique setting that enhances for both inflammation and depression,” McFarland and colleagues wrote. “The appropriate selection of effective antidepressant medication or t... […]
- DripIV Therapy and Hydration in Birmingham Announces Grand Opening Celebration March 1-3 on February 23, 2019 at 5:18 am
The healthy IV infusions and booster shots at DripIV Therapy and Hydration treat common ailments like dehydration, inflammation, vitamin deficiencies, cold and flu symptoms, hangovers, menopause ... […]
- Stem Cell Therapy for Sport Horses on February 21, 2019 at 6:15 am
Not that long ago, training- and performance-related injury treatment was restricted to a few tried-and-true tricks, predominantly controlled exercise, cold hosing, and anti-inflammatory drugs. […]
- Antibody therapy training phagocytes to destroy tumors now tested on patients on February 21, 2019 at 5:01 am
The antibody therapy prevented the growth of tumours ... a large repertoire of functions in immune activation and resolving inflammation. In collaboration with Academician of Science and Professor ... […]
- Understanding Treatment Options for Ankylosing Spondylitis: Medication, Physical Therapy, and More on February 20, 2019 at 11:57 am
Eye inflammation called iritis or uveitis is a common complication ... Some people find that doing these exercises in a pool makes them feel better. But any type of physical therapy is good for AS. It ... […]
- Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing on February 20, 2019 at 9:19 am
The antibody therapy prevented the growth of tumors in several mouse ... Macrophages have a large repertoire of functions in immune activation and resolving inflammation. In collaboration with Academi... […]
- Targeting Inflammation Through Cytokines to Treat Depressive Symptoms on February 20, 2019 at 5:55 am
Dr McIntyre agreed, “Current treatments for depression, eg, cognitive behavioral therapy, medications, lifestyle modification, all have beneficial effects on inflammation. In the future, the use of mo... […]
via Bing News